Abeona Therapeutics Inc.
ABEO
$3.19
$0.020.63%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | -- | 3.50M | -- | 68.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | -- | 3.50M | -- | 68.00K |
| Cost of Revenue | 342.00K | 369.00K | 10.10M | 8.04M | 296.00K |
| Gross Profit | -342.00K | -369.00K | -6.60M | -8.04M | -228.00K |
| SG&A Expenses | 5.83M | 4.16M | 5.02M | 4.00M | 5.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.21M | 11.33M | 15.12M | 12.04M | 12.05M |
| Operating Income | -13.21M | -11.33M | -11.62M | -12.04M | -11.99M |
| Income Before Tax | -16.59M | -11.84M | -16.65M | -9.11M | -7.12M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.59M | -11.84M | -16.65M | -9.11M | -7.12M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.59M | -11.84M | -16.65M | -9.11M | -7.12M |
| EBIT | -13.21M | -11.33M | -11.62M | -12.04M | -11.99M |
| EBITDA | -12.72M | -10.81M | -11.00M | -11.38M | -11.26M |
| EPS Basic | -0.65 | -0.48 | -0.92 | -0.54 | -0.53 |
| Normalized Basic EPS | -0.40 | -0.30 | -0.61 | -0.34 | -0.28 |
| EPS Diluted | -0.65 | -0.48 | -0.92 | -0.54 | -0.53 |
| Normalized Diluted EPS | -0.40 | -0.30 | -0.61 | -0.34 | -0.28 |
| Average Basic Shares Outstanding | 25.69M | 24.80M | 18.02M | 16.90M | 13.42M |
| Average Diluted Shares Outstanding | 25.69M | 24.80M | 18.02M | 16.90M | 13.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
